3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Recruiting
1
Sponsor Class
NIH
2
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Breast Neoplasms
361
Precursor Cell Lymphoblastic Leukemia-Lymphoma
328
Lymphoma
297
Leukemia
254
Multiple Myeloma
246
Leukemia, Myeloid, Acute
241
Lymphoma, Non-Hodgkin
240
Lymphoma, Large B-Cell, Diffuse
238
Leukemia, Lymphocytic, Chronic, B-Cell
220
Myelodysplastic Syndromes
184
Lymphoma, Follicular
176
Hodgkin Disease
165
Lymphoma, Mantle-Cell
163
Burkitt Lymphoma
160
Lymphoma, B-Cell, Marginal Zone
117
Recurrence
115
Lymphoma, Large-Cell, Immunoblastic
95
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
82
Myeloproliferative Disorders
81
Melanoma
78
Neoplasms, Plasma Cell
77
Leukemia, Myeloid, Chronic-Phase
72
Hematologic Neoplasms
72
Leukemia, Myeloid, Accelerated Phase
71
Leukemia, Myelomonocytic, Chronic
69
Lymphoma, B-Cell
65
Dendritic Cell Sarcoma, Interdigitating
64
Triple Negative Breast Neoplasms
63
Ovarian Neoplasms
61
Congenital Abnormalities
59
Interventions
Rituximab
7
Valganciclovir
5
Valacyclovir
3
Gemcitabine
3
Dexamethasone
3
Cisplatin
3
spartalizumab
2
pegaspargase
2
Radiotherapy, Intensity-Modulated
2
Methylprednisolone
2
Lenalidomide
2
Etoposide
2
Doxorubicin
2
Cell Count
2
Blood Specimen Collection
2
valomaciclovir
1
toripalimab
1
ruxolitinib
1
pembrolizumab
1
merphos
1
fludarabine
1
dehydroftorafur
1
avelumab
1
apatinib
1
Zidovudine
1
Watchful Waiting
1
Valproic Acid
1
Vaccines
1
Tenofovir
1
Tegafur
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Epstein-Barr Virus Infections
×
Cyclophosphamide
×
Clear all
NCT06224049
2024-03-12
GI-hNeoT-01
BGI, China
Phase EARLY_PHASE1
Recruiting
6 enrolled